HCV-IN-35
HCV-IN-35 (Compound (R) -3h) is a potent inhibitor of HCV. HCV-IN-35 has the potential for the research infection diseases[1].
Product Specifications
CAS Number
2757963-82-7
UNSPSC
12352005
Target
HCV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/hcv-in-35.html
Solubility
10 mM in DMSO
Smiles
N#CC(C=CC(N(C)CCN(C)C)=C1)=C1CN(CC2)CCN2[C@H](C3=CC=CC=C3)C4=CC=C(C=C4)Cl
Molecular Formula
C30H36ClN5
Molecular Weight
502.09
References & Citations
[1]Wang Y, et al. Design, Synthesis, and Biological Evaluation of 2- ((4-Bisarylmethyl-piperazin-1-yl) methyl) benzonitrile Derivatives as HCV Entry Inhibitors. J Med Chem. 2022 Feb 10;65 (3) :2107-2121.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RC214914L4 10 µg
HNF 4 alpha (HNF4A) (NM_178849) Human Tagged Lenti ORF Clone
Sign In for Pricing
View Details 